Soft tissue implants (e.g., breast, pectoral, chin, facial, lip, and nasal implants) are used in combination with an anti-scarring agent in order to inhibit scarring that may otherwise occur when the implant is placed within an animal.
Web www.patentalert.com
< Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
< Electrical devices and anti-scarring agents
> SYSTEM AND METHOD FOR PROCESSING ANALYTE SENSOR DATA
> Lysyl oxidase-like 1 (LOXL1) and elastogenesis
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT